U.S. Pharma Stock News

PACS Group (NYSE:PACS) has appointed Dr. Patrick H. Conway to its Board of Directors. Dr. Conway is a healthcare leader with experience as CEO of Optum and a senior leader at the Centers for Medicare & Medicaid Services. The appointment is intended to support PACS Group’s focus on value-based care and policy expertise in the post-acute sector. PACS Group, listed on the NYSE under the ticker PACS, operates in the post-acute care space, where reimbursement models and regulatory frameworks...

Polaris (NYSE:PII) has launched an exclusive Slingshot Signature Edition, a limited-run model featuring major product changes and advanced technology. The new Signature Edition expands the Slingshot line with fresh design elements and upgraded in-cabin and performance-focused features. This release adds to Polaris' high-performance offerings in the powersports segment and targets riders seeking a more premium experience. Polaris, best known for its off-road vehicles, snowmobiles, and...

Pomerantz LLP has opened an investigation into Sunrun (NasdaqGS:RUN) over potential securities law violations and other unlawful business practices. The probe follows Sunrun's release of disappointing financial results and negative guidance for 2026. The investigation raises fresh legal and reputational questions for the residential solar provider at a time of heightened investor sensitivity. For investors watching Sunrun at $11.34, the new legal review comes after a sharp pullback, with...

If you are wondering whether C.H. Robinson Worldwide is still reasonably priced after its recent run, this article will walk through what the current share price might be implying about value. The stock last closed at US$179.64, with returns of 9.7% year to date and 78.7% over 1 year, although the share price has seen a 3.0% decline over 7 days and a 9.6% decline over 30 days. Recent coverage around C.H. Robinson Worldwide has focused on its role in global freight forwarding and logistics...

Amer Sports (NYSE:AS) has completed a substantial follow-on equity offering. The transaction included several major financial institutions as co-lead underwriters, including BNP Paribas, UBS, Goldman Sachs, Citigroup, Evercore, and Morgan Stanley. The offering represents a material development for the company’s capital structure and financing plans. Amer Sports, known for its portfolio of sports and outdoor brands, operates at the intersection of performance gear, lifestyle, and...

Ciena (CIEN) opened fiscal Q1 2026 with revenue of US$1.4b and basic EPS of US$1.06, putting a clear focus on how its income statement is scaling alongside earnings. The company has seen quarterly revenue move from US$1.1b in Q1 2025 to US$1.4b in Q1 2026, while basic EPS shifted from US$0.31 to US$1.06 over the same period, set against trailing 12 month EPS of US$1.61. With net income and margins now playing a larger role in the story, this set of results points investors to profitability...

Super Group (SGHC) announced an increase to its annual dividend program. The company declared its first higher quarterly dividend under the new policy. The move signals a shift in how NYSE:SGHC is approaching shareholder returns. For investors watching NYSE:SGHC, this updated dividend approach comes after a period of mixed share performance. The stock is trading at $10.64, with a 30 day return of 18.4% and a 1 year return of 58.7%, while year to date performance shows an 8.6% decline. Over...

The FDA’s decision to lift the clinical hold on Intellia Therapeutics (NTLA) MAGNITUDE Phase 3 trial and the new hereditary angioedema data for lonvoguran ziclumeran have refocused attention on the company’s gene editing pipeline. See our latest analysis for Intellia Therapeutics. At a share price of $13.44, Intellia has seen a 39.85% 90 day share price return and a 45.93% year to date share price return. The 5 year total shareholder return of 79.49% and 3 year total shareholder return of...

Rigel Pharmaceuticals (RIGL) is back in focus after reporting fourth quarter and full year 2025 results, with revenue of US$69.8 million for the quarter and net income of US$268.07 million. See our latest analysis for Rigel Pharmaceuticals. Despite the strong Q4 and full year 2025 earnings, Rigel Pharmaceuticals' recent share price performance has been weak, with a 90 day share price return of 40.99% and a year to date share price return of 30.98%, while the 1 year total shareholder return of...

Viper Energy (NasdaqGS:VNOM) completed a large secondary offering of its Class A common stock by major shareholders, including Diamondback Energy, EnCap Investments, and Oaktree Capital Management. The company is not receiving proceeds from the offering, which was executed at a set offering price. At the same time, Viper is repurchasing units in its operating company from Oaktree affiliates at the same offering price. These moves adjust ownership stakes among key holders and refine how Viper...

If you are wondering whether BorgWarner at around US$51.80 is offering good value today, or if the easy gains are already behind it, this article unpacks what the current price might really mean for you. The stock has seen a 10% decline over the last 7 days, a 2.6% return over 30 days, 11.1% year to date, and 76.3% over the past year, which naturally raises questions about both growth potential and changing views on risk. Recent news coverage has focused broadly on BorgWarner's role in the...

If you are wondering whether Ameriprise Financial is giving you enough value for the risk you are taking, starting with a clear look at its current price and underlying worth can help you size up the stock on your own terms. The share price closed at US$464.89, with recent returns showing a 1.1% decline over 7 days, a 14.8% decline over 30 days, and year to date and 1 year returns of 5.8% and 5.7% declines respectively, set against a 60.7% gain over 3 years and a 122.2% gain over 5...

Carlisle Companies (NYSE:CSL) is reporting exceptional long term earnings growth paired with strong free cash flow margins. The company is now seeing a clear slowdown in organic revenue growth, pointing to a change in its operating environment. This mix of strong profitability and easing sales momentum is raising fresh questions about future business performance and investor expectations. Carlisle Companies, listed on the NYSE under ticker CSL, operates as a diversified manufacturer with...

Asana (NYSE:ASAN) announced a CFO transition, with Aziz Megji promoted to CFO following the resignation of Sonalee Parekh. The company outlined an accelerated AI driven, multi product strategy featuring new offerings such as AI Studio and AI Teammates. Asana is expanding internationally by launching its services on AWS in the Middle East, starting in the UAE, with a focus on regulated and public sector customers. Asana operates in the work management and collaboration software space, where...

Aurora Innovation, NasdaqGS:AUR, has appointed former Meta executive David Wehner to its board of directors. The appointment brings additional large cap technology and governance experience to the autonomous trucking company. Aurora Innovation, trading at $4.49, has had a mixed return profile, with a 16.0% gain year to date and an 18.8% return over the past month, alongside a 36.8% decline over the past year. Over three years, the stock’s return is very large, indicating substantial...

Diana Shipping has increased its acquisition offer for Genco Shipping & Trading (NYSE:GNK) and secured committed financing. The proposal includes a related arrangement for Star Bulk Carriers to acquire a significant portion of Genco's fleet if the deal is completed. Genco's board has confirmed receipt of the revised offer and is currently reviewing the new terms. Genco focuses on dry bulk shipping, moving commodities like iron ore, coal and grain across global trade routes. The fresh offer...

Crown Castle (NYSE:CCI) plans to divest its small cell and fiber businesses in the second half of 2026. The move is aimed at reducing leverage and improving EBITDA margins. If completed, the divestiture will materially reshape the company’s business mix and financial profile. Crown Castle focuses on communications infrastructure, and for years its portfolio has included towers, small cells, and fiber assets. By planning to exit small cells and fiber, the company is signaling a preference...

Cybin (HELP) drew fresh attention after Helus Pharma released topline Phase 2 data for HLP004 in generalized anxiety disorder, showing clinically meaningful symptom reductions, durable responder and remitter rates, and a favorable safety profile in difficult-to-treat patients. See our latest analysis for Cybin. Despite the strong HLP004 readout and recent news flow, including a Form 6-K filing and conference appearances, Cybin’s recent share price moves have been weak. The 7-day share price...

In early March 2026, Webull reported its fourth-quarter and full-year 2025 results, with revenue rising to US$165.2 million for Q4 and US$571 million for the year, while earnings turned positive on a full-year basis but softened in the quarter amid heavier marketing spend. A day later, Solidus Labs announced a partnership with Webull to power digital asset trade surveillance in the US and Canada using its HALO platform, signaling Webull’s intent to pair rapid crypto expansion with more...

Ring Energy (REI) is back in focus after reporting a net loss for both the fourth quarter and full year 2025, along with a large impairment charge and a reset in finance leadership. See our latest analysis for Ring Energy. Despite the recent earnings loss and finance leadership changes, Ring Energy's share price has shown strong momentum, with a 63.7% 3 month share price return and a 70.1% year to date share price return. However, the 5 year total shareholder return of 48.0% signals a weaker...

Plains All American Pipeline (NasdaqGS:PAA) reported a new definitive agreement in a recent SEC Form 8-K filing. The company also disclosed amendments to existing credit agreements with a group of major lenders. These updates relate to Plains All American Pipeline's financing structure and contractual commitments. Plains All American Pipeline focuses on the transportation, storage, and marketing of crude oil and related products, which ties its business closely to broader midstream energy...

DiamondRock Hospitality Company recently reported its fourth-quarter and full-year 2025 results, showing higher net income and earnings per share despite slightly lower sales and revenue, while also updating investors on its ongoing share repurchase program and a quarterly dividend of US$0.09 per share payable in April 2026. The combination of improved profitability, continued capital returns through buybacks and dividends, and upcoming board leadership changes adds new context for how...

Revolution Medicines (NasdaqGS:RVMD) is advancing clinical trials for its RAS(ON) inhibitor pipeline targeting RAS-addicted cancers. The company reported higher R&D spending and wider net losses as it pushes its oncology candidates through the clinic. To reinforce its balance sheet, RVMD filed for a US$1b at-the-market equity program and a US$1.24b shelf registration. Director Mark A. Goldsmith reported significant insider share sales, drawing attention to executive capital...

VSE Corporation recently reported full-year 2025 results, with revenue rising to US$1,112.28 million from US$786.26 million a year earlier, while net income eased to US$11.70 million, and the board affirmed a regular quarterly dividend of US$0.10 per share payable on April 29, 2026. Despite lower overall net income, earnings per share from continuing operations increased year on year and management projected consolidated 2026 revenue growth of about 19% to 23%, including contributions from...